[
  {
    "ts": null,
    "headline": "Prothena’s Partner Bristol Myers Squibb Obtains Fast Track Designation from the U.S. FDA for BMS-986446 (PRX005), an Anti-MTBR-Tau-Targeting Antibody, for the Treatment of Alzheimer’s Disease",
    "summary": "DUBLIN, October 01, 2025--PRTA announced that BMS communicated that the FDA granted Fast Track Designation to BMS-986446, an anti-tau antibody in P2 for Alzheimer's disease.",
    "url": "https://finnhub.io/api/news?id=664d3c5baf0c6b2da4ba5003e55803f853a685565d917a8215ef4247072c5fbe",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759351500,
      "headline": "Prothena’s Partner Bristol Myers Squibb Obtains Fast Track Designation from the U.S. FDA for BMS-986446 (PRX005), an Anti-MTBR-Tau-Targeting Antibody, for the Treatment of Alzheimer’s Disease",
      "id": 136952419,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "DUBLIN, October 01, 2025--PRTA announced that BMS communicated that the FDA granted Fast Track Designation to BMS-986446, an anti-tau antibody in P2 for Alzheimer's disease.",
      "url": "https://finnhub.io/api/news?id=664d3c5baf0c6b2da4ba5003e55803f853a685565d917a8215ef4247072c5fbe"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Rise Late Afternoon",
    "summary": "Health care stocks rose late Wednesday afternoon with the NYSE Health Care Index jumping 3.3% and th",
    "url": "https://finnhub.io/api/news?id=fe573cb08458041ab43cc44e71f2d9d9cfc5102181d4193513c9ab5b4c14d7c3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759347816,
      "headline": "Sector Update: Health Care Stocks Rise Late Afternoon",
      "id": 136952199,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Health care stocks rose late Wednesday afternoon with the NYSE Health Care Index jumping 3.3% and th",
      "url": "https://finnhub.io/api/news?id=fe573cb08458041ab43cc44e71f2d9d9cfc5102181d4193513c9ab5b4c14d7c3"
    }
  },
  {
    "ts": null,
    "headline": "Trump Triggered a Rally in Drug Stocks. Why It Might Not Last.",
    "summary": "The surge in pharmaceutical stocks that followed the administration’s deal with Pfizer on Tuesday was still going strong on Wednesday.",
    "url": "https://finnhub.io/api/news?id=13f5eb24fffe0cf0e1dabf1387b42196ba46fe57fd37f6076214bb13b7713c62",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759346340,
      "headline": "Trump Triggered a Rally in Drug Stocks. Why It Might Not Last.",
      "id": 136952146,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "The surge in pharmaceutical stocks that followed the administration’s deal with Pfizer on Tuesday was still going strong on Wednesday.",
      "url": "https://finnhub.io/api/news?id=13f5eb24fffe0cf0e1dabf1387b42196ba46fe57fd37f6076214bb13b7713c62"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Adopts Veeva Systems Inc. (VEEV)’s Veeva Vault CRM, Boosting Market Confidence",
    "summary": "We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. Veeva Systems Inc. is one of them. Veeva Systems Inc. (NYSE:VEEV), a leading provider of cloud-based software for the life sciences industry, continues to expand its influence through platforms such as Veeva Commercial Cloud, Data Cloud, and […]",
    "url": "https://finnhub.io/api/news?id=ae528e33d2684b8ab8fceec9a68c4af87fa2a0e489ec365e4b792e95d039b986",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759341306,
      "headline": "Bristol Myers Squibb Adopts Veeva Systems Inc. (VEEV)’s Veeva Vault CRM, Boosting Market Confidence",
      "id": 136952422,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. Veeva Systems Inc. is one of them. Veeva Systems Inc. (NYSE:VEEV), a leading provider of cloud-based software for the life sciences industry, continues to expand its influence through platforms such as Veeva Commercial Cloud, Data Cloud, and […]",
      "url": "https://finnhub.io/api/news?id=ae528e33d2684b8ab8fceec9a68c4af87fa2a0e489ec365e4b792e95d039b986"
    }
  },
  {
    "ts": null,
    "headline": "Why Is Bristol-Myers Squibb (BMY) Stock Rocketing Higher Today",
    "summary": "Shares of biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) jumped 5.5% in the afternoon session after the U.S. Food and Drug Administration (FDA) granted Fast Track Designation to its experimental antibody, BMS-986446, for the treatment of early Alzheimer's disease. This special status was intended to help speed up the development and review of drugs that treat serious conditions where there is an unmet medical need. The drug candidate, which was in a mid-stage trial, aimed to slow or d",
    "url": "https://finnhub.io/api/news?id=a798fd07a24ffc6752e92c64f322b2dab2ddf11bffbb0958d6982b54ec7e9395",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759335675,
      "headline": "Why Is Bristol-Myers Squibb (BMY) Stock Rocketing Higher Today",
      "id": 136947533,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Shares of biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) jumped 5.5% in the afternoon session after the U.S. Food and Drug Administration (FDA) granted Fast Track Designation to its experimental antibody, BMS-986446, for the treatment of early Alzheimer's disease. This special status was intended to help speed up the development and review of drugs that treat serious conditions where there is an unmet medical need. The drug candidate, which was in a mid-stage trial, aimed to slow or d",
      "url": "https://finnhub.io/api/news?id=a798fd07a24ffc6752e92c64f322b2dab2ddf11bffbb0958d6982b54ec7e9395"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb’s Anti-MTBR-Tau-Targeting Antibody, BMS-986446, Granted Fast Track Designation by U.S. FDA for the Treatment of Alzheimer’s Disease",
    "summary": "PRINCETON, N.J., October 01, 2025--BMS's Anti-MTBR-Tau-Targeting Antibody, BMS-986446, Granted Fast Track Designation by U.S. FDA for the Treatment of Alzheimer’s Disease",
    "url": "https://finnhub.io/api/news?id=268573e752a2a3e15e8c7737a756d4d5b74dcff6f055eb1a8bb85a5f1a0d293a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759316340,
      "headline": "Bristol Myers Squibb’s Anti-MTBR-Tau-Targeting Antibody, BMS-986446, Granted Fast Track Designation by U.S. FDA for the Treatment of Alzheimer’s Disease",
      "id": 136944376,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "PRINCETON, N.J., October 01, 2025--BMS's Anti-MTBR-Tau-Targeting Antibody, BMS-986446, Granted Fast Track Designation by U.S. FDA for the Treatment of Alzheimer’s Disease",
      "url": "https://finnhub.io/api/news?id=268573e752a2a3e15e8c7737a756d4d5b74dcff6f055eb1a8bb85a5f1a0d293a"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer’s Drug Price Deal with White House Gives Big Pharma a Booster Shot",
    "summary": "A 2024 RAND study found that US drug prices are 278% higher than in 33 other developed countries in the OECD.",
    "url": "https://finnhub.io/api/news?id=00f49db858a494509b37a7effcd3109370829982f3875184f265e9fd35b2747e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759314600,
      "headline": "Pfizer’s Drug Price Deal with White House Gives Big Pharma a Booster Shot",
      "id": 136952151,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "A 2024 RAND study found that US drug prices are 278% higher than in 33 other developed countries in the OECD.",
      "url": "https://finnhub.io/api/news?id=00f49db858a494509b37a7effcd3109370829982f3875184f265e9fd35b2747e"
    }
  },
  {
    "ts": null,
    "headline": "What TrumpRx Means For Controversial Plan To Lower U.S. Drug Prices",
    "summary": "What TrumpRx Means For Controversial Plan To Lower U.S. Drug Prices",
    "url": "https://finnhub.io/api/news?id=a4e04cdc235f20ebb03633aa05fb75eda0611f0b148ce2199bd524b7919f032d",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759312884,
      "headline": "What TrumpRx Means For Controversial Plan To Lower U.S. Drug Prices",
      "id": 136995450,
      "image": "",
      "related": "BMY",
      "source": "DowJones",
      "summary": "What TrumpRx Means For Controversial Plan To Lower U.S. Drug Prices",
      "url": "https://finnhub.io/api/news?id=a4e04cdc235f20ebb03633aa05fb75eda0611f0b148ce2199bd524b7919f032d"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers, Takeda to pool data for AI-based drug discovery",
    "summary": "(Reuters) -Bristol Myers Squibb, Takeda Pharmaceuticals and Astex Pharmaceuticals are coming together to share proprietary data for training an artificial intelligence model to assist drug discovery and development.  The companies are joining a consortium that includes AbbVie and Johnson & Johnson , and will contribute data from several thousand experimentally determined protein–small molecule structures to train an AI model called OpenFold3, life sciences company Apheris said on Wednesday.  The initiative is based on a federated data sharing model, which enables collaboration without exposing sensitive data.",
    "url": "https://finnhub.io/api/news?id=56830a56a9854acb3cb037344cff517e0b1fde231c888d3be6c857c39e534905",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759311087,
      "headline": "Bristol Myers, Takeda to pool data for AI-based drug discovery",
      "id": 136944048,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "(Reuters) -Bristol Myers Squibb, Takeda Pharmaceuticals and Astex Pharmaceuticals are coming together to share proprietary data for training an artificial intelligence model to assist drug discovery and development.  The companies are joining a consortium that includes AbbVie and Johnson & Johnson , and will contribute data from several thousand experimentally determined protein–small molecule structures to train an AI model called OpenFold3, life sciences company Apheris said on Wednesday.  The initiative is based on a federated data sharing model, which enables collaboration without exposing sensitive data.",
      "url": "https://finnhub.io/api/news?id=56830a56a9854acb3cb037344cff517e0b1fde231c888d3be6c857c39e534905"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Gets FDA Fast-Track Designation for BMS-986446 in Alzheimer's",
    "summary": "Bristol Myers Gets FDA Fast-Track Designation for BMS-986446 in Alzheimer's",
    "url": "https://finnhub.io/api/news?id=7983a7514f3d1229c6ec82a6df584ac27a40533dec9c9bdb443cf47383212509",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759303440,
      "headline": "Bristol Myers Gets FDA Fast-Track Designation for BMS-986446 in Alzheimer's",
      "id": 137018308,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Bristol Myers Gets FDA Fast-Track Designation for BMS-986446 in Alzheimer's",
      "url": "https://finnhub.io/api/news?id=7983a7514f3d1229c6ec82a6df584ac27a40533dec9c9bdb443cf47383212509"
    }
  }
]